Lipid- and polymer-based nanoparticle systems for the delivery of CRISPR/Cas9

被引：33

作者：

Ashok, Bhaargavi ^{[1
]}

Peppas, Nicholas A. ^{[1
,2
,3
,4
,5
]}

Wechsler, Marissa E. ^{[6
]}

机构：

[1] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA

[2] Univ Texas Austin, Inst Biomat Drug Delivery & Regenerat Med, Austin, TX 78712 USA

[3] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA

[4] Univ Texas Austin, Coll Pharm, Div Mol Pharmaceut & Drug Delivery, Austin, TX 78712 USA

[5] Univ Texas Austin, Dell Med Sch, Dept Surg & Perioperat Care, Austin, TX 78712 USA

[6] Univ Texas San Antonio, Dept Biomed Engn & Chem Engn, San Antonio, TX 78249 USA

来源：

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY | 2021年 / 65卷

基金：

美国国家卫生研究院;

关键词：

Hydrogels; Nanoparticles; CRISPR; Genome editing; IN-VIVO; TARGETED DELIVERY; MESSENGER-RNA; T-CELLS; GENE; CARRIERS; CANCER; VITRO; DNA; CRISPR-CAS9;

D O I：

10.1016/j.jddst.2021.102728

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The discovery of clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) genome editing systems and their applications in human health and medicine has heralded a new era of biotechnology. However, the delivery of CRISPR therapeutics is arguably the most difficult barrier to overcome for translation to in vivo clinical administration. Appropriate delivery methods are required to efficiently and selectively transport all gene editing components to specific target cells and tissues of interest, while minimizing off-target effects. To overcome this challenge, we discuss and critique nanoparticle delivery strategies, focusing on the use of lipid-based and polymeric-based matrices herein.

引用

页数：13

共 50 条

[21] Biomaterial-Based CRISPR/Cas9 Delivery Systems for Tumor Treatment
Li, Mengmeng
Chen, Fenglei
Yang, Qian
Tang, Qinglai
Xiao, Zian
Tong, Xinying
Zhang, Ying
Lei, Lanjie
Li, Shisheng
BIOMATERIALS RESEARCH, 2024, 28
[22] Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy
Mainini, Francesco
Eccles, Michael R.
MOLECULES, 2020, 25 (11):
[23] CRISPR/Cas9 systems: Delivery technologies and biomedical applications
Yimin Dua
Yanfei Liu
Jiaxin Hu
Xingxing Peng
Zhenbao Liu
Asian Journal of Pharmaceutical Sciences, 2023, 18 (06) : 3 - 33
[24] CRISPR/Cas9 systems: Delivery technologies and biomedical applications
Du, Yimin
Liu, Yanfei
Hu, Jiaxin
Peng, Xingxing
Liu, Zhenbao
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 18 (06)
[25] Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
Zhang, Song
Shen, Jiangtao
Li, Dali
Cheng, Yiyun
THERANOSTICS, 2021, 11 (02): : 614 - 648
[26] Robust in vivo gene editing in mouse hepatocytes with systemic lipid nanoparticle delivery of CRISPR/Cas9 components
Finn, J. D.
Patel, M.
Smith, A. Rhoden
Shaw, L.
Youniss, M.
Ciullo, C.
van Heteren, J.
Lescarbeau, R.
Seitzer, J.
Growe, J.
Dombrowski, C.
Strapps, W. R.
Barnes, T. M.
Morrissey, D. V.
HUMAN GENE THERAPY, 2016, 27 (11) : A131 - A131
[27] Cellular delivery of CRISPR/Cas9 ribonucleoproteins via biomimic lipid nanoparticles
Walther, J.
Evers, M. J. W.
de Jong, O. G.
Vader, P.
Mastrobattista, E.
HUMAN GENE THERAPY, 2018, 29 (12) : A115 - A115
[28] Systems of Delivery of CRISPR/Cas9 Ribonucleoprotein Complexes for Genome Editing
R. N. Amirkhanov
G. A. Stepanov
Russian Journal of Bioorganic Chemistry, 2019, 45 : 431 - 437
[29] Systems of Delivery of CRISPR/Cas9 Ribonucleoprotein Complexes for Genome Editing
Amirkhanov, R. N.
Stepanov, G. A.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2019, 45 (06) : 431 - 437
[30] Improving the efficiency of Cas9/CRISPR genome engineering by optimizing Cas9 delivery
Pelczar, Pawel
Oller, Heide
Kornete, Mara
Schreiner, Dietmar
Hermann, Mario
Jeker, Lukas
TRANSGENIC RESEARCH, 2016, 25 (02) : 255 - 256

← 1 2 3 4 5 →